<DOC>
	<DOCNO>NCT01538992</DOCNO>
	<brief_summary>Sympathetic system important role occurrence symptom heart failure . Renal denervation ablate sympathetic nerve affect pathology heart failure . This interventional therapy improve symptoms life quality .</brief_summary>
	<brief_title>Renal Denervation Patients With Advanced Heart Failure</brief_title>
	<detailed_description>Primary Outcome Measures : • Safety Renal Denervation Heart Failure patient measure Adverse Events Secondary Outcome Measures : • Ventricular function , NYHA functional Class , 6 min walk test , biochemical test Renal function measure Glomerular Filtration Rate ( GFR ) Eligibility Patients population : Volunteers , NYHA Class III-IV heart failure patient . Ages Eligible Study : 18 Years 85 Years Genders Eligible Study : Both Accepts Healthy Volunteers : No</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Heart Failure patient NYHA Class III IV Left Ventricular Ejection Function &lt; 35 % GFR &gt; 45 mL/min/1.73m2 Optimal stable medical therapy Do eligible renal artery anatomy treatment determine Angiography , History prior renal artery intervention Single function kidney . Myocardial Infarction , unstable angina pectoris cerebrovascular Accident within 3 month Systolic BP &lt; 110mmHG Hospitalisation heart failure last 3 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>renal denervation</keyword>
	<keyword>heart failure</keyword>
</DOC>